Clinical Trials
Physicians and researchers interested in more information about clinical trials may
contact Alexion directly at clinicaltrials@alxn.com or visit www.clinicaltrials.gov,
a web site maintained by the U.S. National Institutes of Health.
Investigators are enrolling patients in these and other trials:
Safety and Efficacy Study of Eculizumab in Patients with aHUS
Alexion is conducting four studies to determine whether eculizumab is safe and effective
in the treatment of adult and adolescent patients with plasma therapy-sensitive
and resistant
Atypical Hemolytic-Uremic Syndrome (aHUS).
Learn more about these trials. Read the Alexion press release.
Safety and Efficacy Study of Eculizumab in Patients with Refractory Generalized
Myasthenia Gravis
The purpose of this study is to determine whether eculizumab is safe and effective
in the treatment of patients with generalized myasthenia gravis despite treatment with various
immunosuppressants, such as prednisone, methotrexate, Cellcept, cyclosporine, and
cyclophosphamide, that are currently available.
Learn more about this study.